Search Results - "Duret, Helene"
-
1
Pivotal Role of Innate and Adaptive Immunity in Anthracycline Chemotherapy of Established Tumors
Published in Cancer research (Chicago, Ill.) (15-07-2011)“…We show, in a series of established experimental breast adenocarcinomas and fibrosarcomas induced by carcinogen de novo in mice, that the therapeutic efficacy…”
Get full text
Journal Article -
2
Anti-ErbB-2 mAb therapy requires type I and II interferons and synergizes with anti-PD-1 or anti-CD137 mAb therapy
Published in Proceedings of the National Academy of Sciences - PNAS (26-04-2011)“…Trastuzumab, a monoclonal antibody targeting human epidermal growth factor receptor-2 (HER2/ErbB-2), has become the mainstay of treatment for HER2-positive…”
Get full text
Journal Article -
3
CD73-Deficient Mice Have Increased Antitumor Immunity and Are Resistant to Experimental Metastasis
Published in Cancer research (Chicago, Ill.) (15-04-2011)“…CD73 is a cell-surface enzyme that suppresses immune responses by producing extracellular adenosine. In this study, we employed CD73 gene-targeted mice to…”
Get full text
Journal Article -
4
NLRP3 Suppresses NK Cell―Mediated Responses to Carcinogen-Induced Tumors and Metastases
Published in Cancer research (Chicago, Ill.) (15-11-2012)“…The NLRP3 inflammasome acts as a danger signal sensor that triggers and coordinates the inflammatory response upon infectious insults or tissue injury and…”
Get full text
Journal Article -
5
Opposing Roles for IL-23 and IL-12 in Maintaining Occult Cancer in an Equilibrium State
Published in Cancer research (Chicago, Ill.) (15-08-2012)“…Cancer immunoediting, the process by which the immune system controls tumor growth and shapes tumor immunogenicity, consists of 3 stages: elimination,…”
Get full text
Journal Article -
6
TRF2 inhibits a cell-extrinsic pathway through which natural killer cells eliminate cancer cells
Published in Nature cell biology (01-07-2013)“…Dysfunctional telomeres suppress tumour progression by activating cell-intrinsic programs that lead to growth arrest. Increased levels of TRF2, a key factor in…”
Get full text
Journal Article -
7
NKT cell adjuvant-based tumor vaccine for treatment of myc oncogene-driven mouse B-cell lymphoma
Published in Blood (11-10-2012)“…Immunomodulators are effective in controlling hematologic malignancy by initiating or reactivating host antitumor immunity to otherwise poorly immunogenic and…”
Get full text
Journal Article -
8
Radiotherapy Increases the Permissiveness of Established Mammary Tumors to Rejection by Immunomodulatory Antibodies
Published in Cancer research (Chicago, Ill.) (01-07-2012)“…It is becoming increasingly evident that radiotherapy may benefit from coincident or subsequent immunotherapy. In this study, we examined whether the antitumor…”
Get full text
Journal Article -
9
Anticancer Chemotherapy-Induced Intratumoral Recruitment and Differentiation of Antigen-Presenting Cells
Published in Immunity (Cambridge, Mass.) (18-04-2013)“…The therapeutic efficacy of anthracyclines relies on antitumor immune responses elicited by dying cancer cells. How chemotherapy-induced cell death leads to…”
Get full text
Journal Article -
10
CCL2/CCR2-Dependent Recruitment of Functional Antigen-Presenting Cells into Tumors upon Chemotherapy
Published in Cancer research (Chicago, Ill.) (15-01-2014)“…The therapeutic efficacy of anthracyclines relies, at least partially, on the induction of a dendritic cell- and T-lymphocyte-dependent anticancer immune…”
Get full text
Journal Article -
11
Sun exposure and high preharvest fruit temperatures increase antioxidants, heat shock proteins and thermotolerance of mango fruit (Mangifera indica L.)
Published in New Zealand journal of crop and horticultural science (01-10-2024)“…Preharvest sun-exposure can improve the tolerance of fruit during postharvest handling conditions and thus we examined the postharvest responses of mangos…”
Get full text
Journal Article -
12
Role of γδ T cells in α-galactosylceramide-mediated immunity
Published in The Journal of immunology (1950) (15-04-2012)“…Attempts to harness mouse type I NKT cells in different therapeutic settings including cancer, infection, and autoimmunity have proven fruitful using the…”
Get full text
Journal Article -
13
Type I NKT‐cell‐mediated TNF‐α is a positive regulator of NLRP3 inflammasome priming
Published in European journal of immunology (01-07-2014)“…The NLRP3 inflammasome plays a crucial role in the innate immune response to pathogens and exogenous or endogenous danger signals. Its activity must be…”
Get full text
Journal Article -
14
Transient Foxp3+ regulatory T‐cell depletion enhances therapeutic anticancer vaccination targeting the immune‐stimulatory properties of NKT cells
Published in Immunology and cell biology (01-01-2013)“…The natural killer T (NKT) cell ligand, alpha‐galactosylceramide (α‐GalCer), represents a potential adjuvant to boost immunotherapeutic vaccination strategies…”
Get full text
Journal Article -
15
Anti-IL-23 Monoclonal Antibody Synergizes in Combination with Targeted Therapies or IL-2 to Suppress Tumor Growth and Metastases
Published in Cancer research (Chicago, Ill.) (15-03-2011)“…Immunosuppressive barricades erected by tumors during the evolution of immune escape represent a major obstacle to many potentially effective cancer therapies…”
Get full text
Journal Article -
16
Type I NKT ‐cell‐mediated TNF ‐α is a positive regulator of NLRP 3 inflammasome priming
Published in European journal of immunology (01-07-2014)“…The NLRP 3 inflammasome plays a crucial role in the innate immune response to pathogens and exogenous or endogenous danger signals. Its activity must be…”
Get full text
Journal Article -
17
Type I NKT-cell-mediated TNF-[alpha] is a positive regulator of NLRP3 inflammasome priming
Published in European journal of immunology (01-07-2014)“…The NLRP3 inflammasome plays a crucial role in the innate immune response to pathogens and exogenous or endogenous danger signals. Its activity must be…”
Get full text
Journal Article -
18
Role of gamma delta T Cells in alpha -Galactosylceramide-Mediated Immunity
Published in The Journal of immunology (1950) (15-04-2012)“…Attempts to harness mouse type I NKT cells in different therapeutic settings including cancer, infection, and autoimmunity have proven fruitful using the…”
Get full text
Journal Article -
19
Studying the role of the immune system on the antitumor activity of a Hedgehog inhibitor against murine osteosarcoma
Published in Oncoimmunology (01-11-2012)“…Recent evidence demonstrates that the efficacy of conventional anticancer therapies including chemotherapy requires a functional immune system. Here, we…”
Get full text
Journal Article -
20
Le musée face à l’art de son temps
Published in 20 & 21 (Imprimé) (01-06-2019)Get full text
Journal Article